Aytu Biopharma (AYTU) Goodwill (2015 - 2022)

Aytu Biopharma (AYTU) has 7 years of Goodwill data on file, last reported at $8.6 million in Q1 2022.

• On a quarterly basis, Goodwill fell 77.1% year-over-year to $8.6 million in Q1 2022; TTM through Mar 2022 was $8.6 million, a 77.1% decrease from a year earlier, with the FY2021 full-year figure at $65.8 million, up 134.25% from the prior year.
• Goodwill for Q1 2022 stood at $8.6 million, down from $46.3 million in the prior quarter.
• Over the last five years, Goodwill for AYTU reached as high as $65.8 million in Q2 2021 and fell as low as $8.6 million in Q1 2022.
• Historically, Goodwill has averaged $32.9 million across 4 years, with a median of $28.1 million in 2020.
• Across the five-year window, Goodwill soared 134.25% in 2021 and tumbled 77.1% in 2022, its largest moves.
• Year by year, Goodwill stood at $15.4 million in 2019, then jumped by 82.56% to $28.1 million in 2020, then soared by 65.0% to $46.3 million in 2021, then sank by 81.37% to $8.6 million in 2022.
• Per Business Quant data, the three most recent Goodwill figures were $8.6 million in Q1 2022, $46.3 million in Q4 2021, and $46.3 million in Q3 2021.